1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Crump, M.P. Rajarathnam, K. Sykes, B.D. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 273 22471 22479 10.1074/jbc.273.35.22471 9712872 Solution structure of eotaxin, a chemokine that selectively recruits eosinophils in allergic inflammation. 1998 10.2210/pdb1eot/pdb pdb_00001eot 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 BOTH SYNTHETIC AND RECOMBINANT SAMPLES WERE PREPARED. RECOMBINANT SAMPLES WERE UNIFORMLY LABELLED WITH N15. 8380.936 EOTAXIN 1 man polymer no no GPASVPTTCCFNLANRKIPLQRLESYRRITSGKCPQKAVIFKTKLAKDICADPKKKWVQDSMKYLDQKSPTPKP GPASVPTTCCFNLANRKIPLQRLESYRRITSGKCPQKAVIFKTKLAKDICADPKKKWVQDSMKYLDQKSPTPKP A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia Escherichia coli sample BOTH SYNTHETIC AND RECOMBINANT SAMPLES WERE PREPARED YES BL21 9606 Homo sapiens 469008 Escherichia coli BL21(DE3) BL21 (DE3) PET15B database_2 pdbx_database_status pdbx_nmr_exptl_sample_conditions pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations Experimental preparation Other 1 0 1999-01-13 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-16 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _pdbx_nmr_exptl_sample_conditions.pressure_units _pdbx_nmr_software.name Y BNL 1998-06-17 REL REL RESONANCE ASSIGNMENTS WERE ACHIEVED USING STANDARD TWO- AND THREE-DIMENSIONAL SEQUENTIAL ASSIGNMENT TECHNIQUES. NMR RESTRAINTS WERE EXTRACTED FROM 50, 75 AND 150 MS NOESY EXPERIMENTS. COUPLING CONSTANTS WERE CALCULATED FROM AN HNHA EXPERIMENT WITH UNIFORMLY LABELLED EOTAXIN. STRUCTURES WERE SELECTED WITH NO VIOLATIONS > 0.3 A OR DIHEDRAL ANGLES > 0.5 A AND GOOD COVALENT GEOMETRY. 40 1 DQF-COSY NOESY TOCSY RPESY 13C-HSQC 13C-EDITED HMQC-NOESY 15N-NOESY HSQC 15N TOCSY HSQC 20mM SODIUM ACETATE 5.00 1 atm 303 K STRUCTURES WERE REFINED WITH MULTIPLE ROUNDS OF SIMULATED ANNEALING WITH THE ADDITION OF NEW NOES AND CORRECTION OF UNAMBIGUOUS NOES. PHI ANGLES WERE ONLY ADDED WHEN THEY AGREED WITH THE PURELY NOE DRIVEN CONVERGENCE OF THAT ANGLE IN INITIAL STRUCTURE CALCULATIONS. OTHER REFINEMENT INFORMATION CAN BE FOUND IN THE JRNL CITATION ABOVE. simulated annealing 90% H2O/10% H2O OR 100% D2O. BUFFER ALSO CONTAINED 1MM DSS AND 1MM SODIUM AZIDE. BRUNGER refinement X-PLOR 3.1 structure solution VNMR structure solution X-PLOR structure solution NMRPipe 500 Varian UNITY 600 600 Varian INOVA 500 GLY 1 n 1 GLY 1 A PRO 2 n 2 PRO 2 A ALA 3 n 3 ALA 3 A SER 4 n 4 SER 4 A VAL 5 n 5 VAL 5 A PRO 6 n 6 PRO 6 A THR 7 n 7 THR 7 A THR 8 n 8 THR 8 A CYS 9 n 9 CYS 9 A CYS 10 n 10 CYS 10 A PHE 11 n 11 PHE 11 A ASN 12 n 12 ASN 12 A LEU 13 n 13 LEU 13 A ALA 14 n 14 ALA 14 A ASN 15 n 15 ASN 15 A ARG 16 n 16 ARG 16 A LYS 17 n 17 LYS 17 A ILE 18 n 18 ILE 18 A PRO 19 n 19 PRO 19 A LEU 20 n 20 LEU 20 A GLN 21 n 21 GLN 21 A ARG 22 n 22 ARG 22 A LEU 23 n 23 LEU 23 A GLU 24 n 24 GLU 24 A SER 25 n 25 SER 25 A TYR 26 n 26 TYR 26 A ARG 27 n 27 ARG 27 A ARG 28 n 28 ARG 28 A ILE 29 n 29 ILE 29 A THR 30 n 30 THR 30 A SER 31 n 31 SER 31 A GLY 32 n 32 GLY 32 A LYS 33 n 33 LYS 33 A CYS 34 n 34 CYS 34 A PRO 35 n 35 PRO 35 A GLN 36 n 36 GLN 36 A LYS 37 n 37 LYS 37 A ALA 38 n 38 ALA 38 A VAL 39 n 39 VAL 39 A ILE 40 n 40 ILE 40 A PHE 41 n 41 PHE 41 A LYS 42 n 42 LYS 42 A THR 43 n 43 THR 43 A LYS 44 n 44 LYS 44 A LEU 45 n 45 LEU 45 A ALA 46 n 46 ALA 46 A LYS 47 n 47 LYS 47 A ASP 48 n 48 ASP 48 A ILE 49 n 49 ILE 49 A CYS 50 n 50 CYS 50 A ALA 51 n 51 ALA 51 A ASP 52 n 52 ASP 52 A PRO 53 n 53 PRO 53 A LYS 54 n 54 LYS 54 A LYS 55 n 55 LYS 55 A LYS 56 n 56 LYS 56 A TRP 57 n 57 TRP 57 A VAL 58 n 58 VAL 58 A GLN 59 n 59 GLN 59 A ASP 60 n 60 ASP 60 A SER 61 n 61 SER 61 A MET 62 n 62 MET 62 A LYS 63 n 63 LYS 63 A TYR 64 n 64 TYR 64 A LEU 65 n 65 LEU 65 A ASP 66 n 66 ASP 66 A GLN 67 n 67 GLN 67 A LYS 68 n 68 LYS 68 A SER 69 n 69 SER 69 A PRO 70 n 70 PRO 70 A THR 71 n 71 THR 71 A PRO 72 n 72 PRO 72 A LYS 73 n 73 LYS 73 A PRO 74 n 74 PRO 74 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O ILE 49 A O ILE 49 A N PHE 41 A N PHE 41 A O ALA 38 A O ALA 38 A N ILE 29 A N ILE 29 1 A ALA 3 -69.32 84.05 1 A SER 4 62.99 -80.04 1 A THR 8 -139.11 -66.51 1 A SER 25 -170.08 -175.29 1 A THR 30 -164.18 31.73 1 A LYS 44 -97.68 30.03 1 A SER 69 -57.07 174.95 1 A LYS 73 51.53 164.76 model building X-PLOR 3.1 refinement X-PLOR 3.1 phasing X-PLOR 3.1 SOLUTION NMR STRUCTURE OF EOTAXIN, MINIMIZED AVERAGE STRUCTURE 1 Y N A TRP 57 A TRP 57 HELX_P A LYS 68 A LYS 68 1 1 12 disulf 2.020 A CYS 9 A SG CYS 9 1_555 A CYS 34 A SG CYS 34 1_555 disulf 2.021 A CYS 10 A SG CYS 10 1_555 A CYS 50 A SG CYS 50 1_555 CYTOKINE CYTOKINE, CHEMOKINE, PROTEIN SYNTHESIS, EOTAXIN, SOLUTION STRUCTURE, CCR3, EOSINOPHIL CCL11_HUMAN UNP 1 1 P51671 MKVSAALLWLLLIAAAFSPQGLAGPASVPTTCCFNLANRKIPLQRLESYRRITSGKCPQKAVIFKTKLAKDICADPKKKW VQDSMKYLDQKSPTPKP 24 97 1EOT 1 74 P51671 A 1 1 74 3 anti-parallel anti-parallel A ASP 48 A ASP 48 A ALA 51 A ALA 51 A ALA 38 A ALA 38 A THR 43 A THR 43 A SER 25 A SER 25 A ILE 29 A ILE 29 1 P 1